INVESTIGATING THE RELATIONSHIP BETWEEN BLOOD KLOTHO LEVELS AND GLYCATED HEMOGLOBIN IN DIABETIC NEPHROPATHY PATIENTS
##semicolon##
Key words: Klotho, glycated hemoglobin, diabetic nephropathy, glomerular filtration rate, kidney dysfunction.##article.abstract##
Diabetic nephropathy (DN) remains a significant complication of diabetes mellitus, characterized by progressive kidney damage due to prolonged hyperglycemia. Glycated hemoglobin (HbA1c) serves as a key marker for long-term glycemic control in diabetic patients, representing the average blood glucose levels over the preceding 2-3 months. Higher HbA1c levels are associated with an increased risk of diabetic complications, including nephropathy.
Recent research has highlighted Klotho, a protein with renoprotective properties, as a potential modulator of kidney health in DN. Klotho is primarily expressed in the kidneys and has anti-inflammatory, anti-fibrotic, and antioxidant effects, which may provide protection against the pathophysiological processes that damage renal function in diabetes. This study explores the relationship between blood Klotho levels and HbA1c in DN patients, aiming to determine how glycemic control correlates with Klotho concentrations and whether Klotho could serve as an indicator of kidney protection in these patients.
##submission.citations##
1. Kuro-o, M. (2012). Klotho and aging. Biochimica et Biophysica Acta (BBA) - General Subjects, 1822(3), 402-410.
2. Semba, R. D., Cappola, A. R., Sun, K., Bandinelli, S., Dalal, M., & Ferrucci, L. (2011). Plasma Klotho and cardiovascular disease in adults. Journal of the American Geriatrics Society, 59(9), 1596-1601.
3. Navarro-González, J. F., Mora-Fernández, C., Muros de Fuentes, M., & García-Pérez, J. (2011). Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology, 7(6), 327-340.
4. Botirova N. A. DIAGNOSTIC SIGNIFICANCE OF KLOTHO AND CYSTATIN C IN THE EARLY STAGE OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITEUS //Proceedings of International Conference on Scientific Research in Natural and Social Sciences. – 2024. – Т. 3. – №. 2. – С. 111-113.
5. Botirova N. A., Mirahmedova H. T. SIGNIFICANCE OF STANDARD AND NEWLY STUDIED BIOMARKERS IN THE DIAGNOSIS OF ADVANCED CHRONIC KIDNEY DISEASE AGAINST THE BACKGROUND OF DIABETIC NEPHROPATHY IN TYPE 2 DIABETES //Western European Journal of Medicine and Medical Science. – 2023. – Т. 1. – №. 3. – С. 5-10.
6. Botirova N. A. THE SIGNIFICANCE OF THE KLOTHO PROTEIN AT THE EARLY STAGE OF DIABETIC NEPHROPATHY //Proceedings of Scientific Conference on Multidisciplinary Studies. – 2024. – Т. 3. – №. 2. – С. 28-29.
7. Мирахмедова Х. Т., Ботирова Н. А. Кандли диабетнинг 2-типида ривожланган сурункали буйрак касаллигини эрта ташхислашда Клото хамда цистатин С нинг ахамияти: дис. – Ташкентская медицинская академия, Ташкент, Узбекистан, 2024.
8. Мирахмедова Х. Т., Ботирова Н. А. 2-тип кандли диабет билан огриган беморларда диабетик нефропатиянинг эрта боскичида клото омилининг ахамияти: дис. – Ташкентская медицинская академия, Ташкент, Узбекистан, 2024.
9. Мирахмедова, Хилола Тухтасиновна, and Ботирова Нигина. "Actual Problems of Diabetic Nephropathy, Risk Factors, Stages, Progression, Mechanism, Diagnosis and Management." (2022).
